Back

Acceptability of Doxy-PEP Among Men Who Have Sex With Men in New York City: Findings From the 2023 National HIV Behavioral Surveillance Survey

Meunier, E.; Rivera, A.; Rodriguez, K.; Martinez, P. A.; Edelstein, Z.

2026-05-30 sexual and reproductive health
10.64898/2026.05.28.26354355 medRxiv
Show abstract

In the United States, gay, bisexual, and other men who have sex with men (MSM) experience a disproportionate burden of sexually transmitted infections (STIs), with notable racial/ethnic disparities. Doxycycline post-exposure prophylaxis (doxy-PEP) has emerged as a promising strategy to prevent bacterial STIs. This study analyzed 2023 National HIV Behavioral Surveillance data to examine doxy-PEP awareness, use, and intent to use among MSM in New York City (NYC), in a predominantly Hispanic/Latino sample. Among 134 participants, awareness and prior use were low (38.8% and 9.0%, respectively), but intent to use was high (75.4%). In Poisson regression models, intent was higher among participants reporting non-injection drug use and 2-10 partners in the past 12 months, while marginally lower among those above the Federal Poverty Level and recent migrants. Findings suggest doxy-PEP is acceptable for MSM in NYC, but addressing barriers among low-income groups and recent migrants is critical to reducing disparities.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.